sglt2 inhibitors vs glp 1 agonists and GLP-1 Receptor in Diabetic Kidney Disease: Evolving Evidence and Clinical Application Use of GLP-1 Receptor Agonists
Description
Working solutions of GEP44, GEP12, Ex-4, or vehicle control were administered by subcutaneous injection once daily at the start of the dark cycle using a 1 cc 29G insulin syringe
( 10.1016/j.cmet.2019.08.009) [DOI] [PMC free article] [PubMed] [Google Scholar] Svoboda M Tastenoy M Vertongen P & Robberecht P
2026 Jan 08
Below, the best protein bars of 2026
10.1172/jci.insight.170419
